Literature DB >> 17617762

Age-specific impact of self-monitored pulse pressure on hypertensive target organ damage in treated hypertensive patients.

Kazuo Eguchi1, Yoshio Matsui, Seiichi Shibasaki, Joji Ishikawa, Satoshi Hoshide, Shizukiyo Ishikawa, Tomoyuki Kabutoya, Joseph E Schwartz, Thomas G Pickering, Kazuyuki Shimada, Kazuomi Kario.   

Abstract

The authors examined the relationship of clinic and self-measured pulse pressure with target organ damage in 597 treated hypertensive patients without clinical evidence of renal dysfunction or a history of heart failure. The cross-sectional relationships of plasma brain natriuretic peptide (BNP) and urinary albumin/creatinine ratio with clinic and self-monitored pulse pressures were estimated in age tertile groups: younger than 67 years (n=193), 67 to 75 years (n=216), and older than 75 years (n=188), controlling for various confounding factors. In multivariable analyses, both clinic and self-monitored higher pulse pressures were associated with increased urinary albumin/creatinine ratio in all 3 age groups. Self-monitored higher pulse pressure, but not clinic pulse pressure, was consistently associated with increased BNP in the younger and middle-aged patients. In the very old (older than 75 years), however, there were no consistent associations between pulse pressure measures and BNP. More studies are needed in the evaluation of cardiac risk with hemodynamic measures in the very old.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617762      PMCID: PMC8109936          DOI: 10.1111/j.1524-6175.2007.06672.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  45 in total

1.  Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation.

Authors: 
Journal:  Blood Press Monit       Date:  1998-08       Impact factor: 1.444

2.  Pulse pressure and mortality in older people.

Authors:  R J Glynn; C U Chae; J M Guralnik; J O Taylor; C H Hennekens
Journal:  Arch Intern Med       Date:  2000-10-09

3.  Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.

Authors:  Bryan Williams; Peter S Lacy; Simon M Thom; Kennedy Cruickshank; Alice Stanton; David Collier; Alun D Hughes; H Thurston; Michael O'Rourke
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

4.  Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure.

Authors:  Johji Kato; Kazuo Kitamura; Tomohiko Uemura; Kenji Kuwasako; Toshihiro Kita; Kenji Kangawa; Tanenao Eto
Journal:  Hypertens Res       Date:  2002-11       Impact factor: 3.872

5.  Value of home blood pressures as predictor of target organ damage in mild arterial hypertension.

Authors:  Giuseppe Mulè; Gregorio Caimi; Santina Cottone; Emilio Nardi; Giuseppe Andronico; Giuseppe Piazza; Vito Volpe; Maria Rosa Federico; Giovanni Cerasola
Journal:  J Cardiovasc Risk       Date:  2002-04

6.  Reproducibility of home blood pressure measurements over a 1-year period.

Authors:  M Sakuma; Y Imai; K Nagai; N Watanabe; H Sakuma; N Minami; H Satoh; K Abe
Journal:  Am J Hypertens       Date:  1997-07       Impact factor: 2.689

7.  Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

Authors:  T Nishikimi; F Yoshihara; A Morimoto; K Ishikawa; T Ishimitsu; Y Saito; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

8.  Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients.

Authors:  Sei Tsunoda; Yuhei Kawano; Takeshi Horio; Naoki Okuda; Shuichi Takishita
Journal:  Hypertens Res       Date:  2002-03       Impact factor: 3.872

9.  Hypertensive target-organ damage in the very elderly.

Authors:  Cianán O'Sullivan; Joe Duggan; Simon Lyons; John Thornton; Michael Lee; Eoin O'Brien
Journal:  Hypertension       Date:  2003-07-14       Impact factor: 10.190

10.  Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment.

Authors:  M H Alderman; H Cohen; S Madhavan
Journal:  J Hypertens       Date:  1998-06       Impact factor: 4.844

View more
  1 in total

1.  Single-pill combination of cilnidipine, an L-/N-type calcium channel blocker, and valsartan effectively reduces home pulse pressure in patients with uncontrolled hypertension and sympathetic hyperactivity: The HOPE-Combi survey.

Authors:  Kazuomi Kario; Saori Matsuda; Shinobu Nagahama; Yoshiki Kurose; Hitoshi Sugii; Tsukasa Teshima; Noriyuki Suzuki
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-03       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.